Kolexia
De Castro Nathalie
Pneumologie
Hôpital Saint-Louis
Paris, France
110 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH COVID-19 Tuberculose Co-infection Pneumonie à Pneumocystis Infections opportunistes liées au SIDA Pneumopathie infectieuse Infections opportunistes Virémie

Industries

MSD
1 collaboration(s)
Dernière en 2018
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trial.
The lancet. HIV   01 mars 2024
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial.
The Journal of infection   16 février 2024
Failure of bamlanivimab with selection of E484K mutation in an allogeneic stem cell transplant recipient with nosocomial SARS-CoV-2 infection.
Antiviral therapy   15 février 2024
The Tuberculosis Sentinel Research Network (TB-SRN) of the International epidemiology Databases to Evaluate AIDS (IeDEA): protocol for a prospective cohort study in Africa, Southeast Asia and Latin America.
BMJ open   09 janvier 2024
Morbidity & risk factors of COVID-19 in people living with HIV-1 in Europe: NEAT ID HIV-CoCo study
HIV medicine Congress 2023   01 décembre 2023
ANRS 177 DUETTO randomized, open-label and multicentric trial evaluating the non-inferiority of maintenance antiretroviral dual therapy taken 4 consecutive days per week versus dual therapy 7/7 days per week
HIV medicine Congress 2023   01 décembre 2023
Low cabotegravir trough concentrations without oral lead-in in patients with HIV-1 infection switching to long-acting cabotegravir and rilpivirine
HIV medicine Congress 2023   01 décembre 2023
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial.
BMJ medicine   27 octobre 2023
Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19.
Infectious diseases now   14 juillet 2023
Updated mortality and causes of death in 2020-2021 in people with HIV: a multicenter study in France.
AIDS (London, England)   07 juillet 2023